Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1978-07-21
1980-09-23
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
128 12, 424 15, 424 9, A61K 2900, A61K 4300
Patent
active
042243033
ABSTRACT:
Particulate sources of signal which can be detected outside the body of a patient are introduced into the circulating blood and are tracked in three dimensions in the region of the heart using suitable detectors disposed about the patient's chest. This permits the sequence of positions of each particle to be recorded as a function of time as each particle flows through a coronary vessel. Data analyses of these recordings of particle positions provide information about the velocity of blood flow through the course of each coronary artery. This velocity information is used to determine the extent, severity and location of stenotic lesions of the coronary arteries.
REFERENCES:
patent: 3812245 (1974-05-01), Dugan
patent: 3933996 (1976-01-01), Charlton et al.
patent: 3995020 (1976-11-01), Dandamudi
patent: 4126669 (1978-11-01), Rothman et al.
Nucker Christine M.
Padgett Benjamin R.
Smith A. C.
Smith A. C.
LandOfFree
Signalling particles for introduction into blood flowing through does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Signalling particles for introduction into blood flowing through, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Signalling particles for introduction into blood flowing through will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-644682